These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 364151)

  • 1. Carcinogenicity and mutagenicity testing of three isomeric N-nitroso-N-methylaminopyridines in rats.
    Preussmann R; Habs M; Pool BL
    J Natl Cancer Inst; 1979 Jan; 62(1):153-6. PubMed ID: 364151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenic activity of three isomeric N-nitroso-N-methylaminopyridines towards Escherichia coli K-12 in in vitro and animal-mediated assays.
    Kerklaan P; Bouter S; Mohn G
    Carcinogenesis; 1982; 3(4):415-21. PubMed ID: 7046976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity studies in Salmonella typhimurium on some carcinogenic N-nitramines in vitro and in the host-mediated assay in rats.
    Khudoley V; Malaveille C; Bartsch H
    Cancer Res; 1981 Aug; 41(8):3205-10. PubMed ID: 7018677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure activity studies with N-nitrosamines using Salmonella typhimurium and Escherichia coli.
    Rao TK; Epler JL; Lijinsky W
    IARC Sci Publ; 1982; (41):543-51. PubMed ID: 6754596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of carcinogenic and non-carcinogenic N-nitroso-N-methylaminopyridines. I. Investigations in vitro.
    Heydt G; Eisenbrand G; Preussmann R
    Carcinogenesis; 1982; 3(4):445-8. PubMed ID: 6896474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative comparisons between carcinogenicity, mutagenicity and electrophilicity of direct-acting N-nitroso compounds and other alkylating agents.
    Bartsch H; Malaveille C; Tomatis L; Brun G; Dodet B; Terracini B
    IARC Sci Publ; 1982; (41):525-32. PubMed ID: 6754595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens.
    McMahon RE; Cline JC; Thompson CZ
    Cancer Res; 1979 Mar; 39(3):682-93. PubMed ID: 371791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogenicity of methylated derivatives of N-nitrosodiethylamine and related compounds in Sprague-Dawley rats.
    Lijinsky W; Taylor HW
    J Natl Cancer Inst; 1979 Feb; 62(2):407-10. PubMed ID: 283272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of mutagenicities of N-nitrosamines on Salmonella typhimurium TA100 and Escherichia coli WP2 uvrA/pKM101 using rat and hamster liver s9.
    Araki A; Muramatsu M; Matsushima T
    Gan; 1984 Jan; 75(1):8-16. PubMed ID: 6373472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of carcinogenic and non-carcinogenic N-nitroso-N-methylaminopyridines. II. Investigations in vivo.
    Heydt-Zapf G; Haubner R; Preussmann R; Eisenbrand G
    Carcinogenesis; 1983; 4(6):729-31. PubMed ID: 6688042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carcinogenicity of N-nitroso compounds].
    Montesano R
    Ann Nutr Aliment; 1976; 30(5-6):867-71. PubMed ID: 1030226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and mutagenicity of N-nitroso-2-methoxy-2,6-dimethylmorpholine in hamsters.
    Gingell R; Brunk G; Nagel D; Wallcave L; Walker B; Pour P
    J Natl Cancer Inst; 1980 Jan; 64(1):157-61. PubMed ID: 6928040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of 3-methyl substitution on the carcinogenicity of nitroso-4-piperidone.
    Singer GM; Reuber MD; Mangino MM; Lijinsky W
    Carcinogenesis; 1984 Oct; 5(10):1351-3. PubMed ID: 6488456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The superiority of hamster liver microsomal fraction for activating nitrosamines to mutagens in Salmonella typhimurium.
    Lijinsky W; Andrews AW
    Mutat Res; 1983 Oct; 111(2):135-44. PubMed ID: 6355832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenic effects of Di-n-propylnitrosamine, beta-hydroxypropyl-n-propylnitrosamine, and methyl-n-propylnitrosamine on Sprague-Dawlay rats.
    Reznik G; Mohr U; Krüger FW
    J Natl Cancer Inst; 1975 Apr; 54(4):937-43. PubMed ID: 1127723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenicity of N-nitroso-3-hydroxypyrrolidine and dose-response study with N-nitrosopiperidine in rats.
    Eisenbrand G; Habs M; Schmähl D; Preussmann R
    IARC Sci Publ; 1980; (31):657-66. PubMed ID: 7228288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.